87 related articles for article (PubMed ID: 7931819)
1. Serum pseudocholinesterase and very-low-density lipoprotein metabolism.
Kutty KM; Payne RH
J Clin Lab Anal; 1994; 8(4):247-50. PubMed ID: 7931819
[TBL] [Abstract][Full Text] [Related]
2. Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?
Rustemeijer C; Schouten JA; Voerman HJ; Beynen AC; Donker AJ; Heine RJ
Clin Sci (Lond); 2001 Jul; 101(1):29-35. PubMed ID: 11410111
[TBL] [Abstract][Full Text] [Related]
3. Identification and molecular characterization of propionylcholinesterase, a novel pseudocholinesterase in rice.
Yamamoto K; Momonoki YS
Plant Signal Behav; 2021 Nov; 16(11):1961062. PubMed ID: 34334124
[TBL] [Abstract][Full Text] [Related]
4. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
[TBL] [Abstract][Full Text] [Related]
5. Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice.
Kutty KM; Huang SN; Kean KT
Experientia; 1981 Nov; 37(11):1141-2. PubMed ID: 7318992
[TBL] [Abstract][Full Text] [Related]
6. A study of pseudocholinesterase induction in experimental obesity.
Kean KT; Kutty KM; Huang SN; Jain R
J Am Coll Nutr; 1986; 5(3):253-61. PubMed ID: 3734272
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
Niu YG; Evans RD
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.
Zhang B; Shen C; Jin J; Song Y; Zhao Z; Zhang X; Wang G; Fan Y; Mi Y; Hu S; Cui Y; Zhou L; He Z; Yu W; Han W
Int Urol Nephrol; 2016 Dec; 48(12):1993-1999. PubMed ID: 27554671
[TBL] [Abstract][Full Text] [Related]
9. Pseudocholinesterase levels in patients under electroconvulsive therapy.
Küçükosman G; Pişkin Ö; Hancı V; Okyay RD; Ayoğlu H; Yurtlu BS; Akın M; Turan IÖ
Saudi Med J; 2018 Jan; 39(1):103-106. PubMed ID: 29332117
[TBL] [Abstract][Full Text] [Related]
10. Pseudocholinesterase in alloxan-diabetic rats.
Oresković K; Kunec-Vajić E
Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):117-20. PubMed ID: 1462046
[TBL] [Abstract][Full Text] [Related]
11. Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes.
Duerden JM; Gibbons GF
Biochem J; 1988 Nov; 255(3):929-35. PubMed ID: 3214432
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus.
Abbott CA; Mackness MI; Kumar S; Olukoga AO; Gordon C; Arrol S; Bhatnagar D; Boulton AJ; Durrington PN
Clin Sci (Lond); 1993 Jul; 85(1):77-81. PubMed ID: 8149699
[TBL] [Abstract][Full Text] [Related]
13. Restoration in vitro of normal rates of very-low-density lipoprotein triacylglycerol and apoprotein B secretion in hepatocyte cultures from diabetic rats.
Duerden JM; Gibbons GF
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):167-71. PubMed ID: 8363568
[TBL] [Abstract][Full Text] [Related]
14. Molecular forms of pseudocholinesterase in patients with Crohn's disease.
Novacek G; Vogelsang H; Maier-Dobersberger T; Kapiotis S; Lochs H; Gmeiner B
Digestion; 1993; 54(4):243-7. PubMed ID: 8243837
[TBL] [Abstract][Full Text] [Related]
15. Pseudocholinesterase Enzyme Deficiency in Adıyaman City Area.
Abdullayev R; Küçükebe ÖB; Kaya R; Çelik B; Kuşderci H; Duran M; Uludağ Ö; Öterkuş M; Buyrukcan A; Sabuncu Ü; Arpacı A
Turk J Anaesthesiol Reanim; 2015 Dec; 43(6):381-6. PubMed ID: 27366534
[TBL] [Abstract][Full Text] [Related]
16. Pseudocholinesterase activity in human cerebrospinal fluid.
Kambam JR; Horton B; Parris WC; Hyman SA; Berman ML; Sastry BV
Anesth Analg; 1989 Apr; 68(4):486-8. PubMed ID: 2929981
[TBL] [Abstract][Full Text] [Related]
17. Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals.
Duerden JM; Bartlett SM; Gibbons GF
Biochem J; 1989 Aug; 262(1):313-9. PubMed ID: 2684155
[TBL] [Abstract][Full Text] [Related]
18. The influence of catecholamines on pseudocholinesterase enzymatic activity. Results of a laboratory investigation.
Ledowski T; Paech MJ; Clarke M; Schug SA
J Clin Monit Comput; 2006 Oct; 20(5):329-32. PubMed ID: 16953463
[TBL] [Abstract][Full Text] [Related]
19. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association studies reveal genetic loci associated with plasma cholinesterase activity in ducks.
Xu Y; Liu H; Jiang Y; Fan W; Hu J; Zhang Y; Guo Z; Xie M; Huang W; Liu X; Zhou Z; Hou S
Anim Genet; 2019 Jun; 50(3):287-292. PubMed ID: 30994195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
